Department of Pharmacy, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.
Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, China.
BMJ Open. 2023 May 12;13(5):e069397. doi: 10.1136/bmjopen-2022-069397.
An up-to-date, detailed global analysis of the current status of the metabolic-attributed cardiovascular disease (CVD) burden has not been reported. Therefore, we investigated the global burden of metabolic-attributed CVD and its association with socioeconomic development status over the past 30 years.
Data on the burden of metabolic-attributed CVD were taken from the 2019 Global Burden of Disease (GBD) study. Metabolic risk factors of CVD included high fasting plasma glucose, high low-density lipoprotein cholesterol (LDL-c), high systolic blood pressure (SBP), high body mass index (BMI) and kidney dysfunction. Numbers and age-standardised rates (ASR) of disability-adjusted life-years (DALYs) and deaths were extracted and stratified by sex, age, Socio-demographic Index (SDI) level, country and region.
The ASR of metabolic-attributed CVD DALYs and deaths decreased by 28.0% (95% UI 23.8% to 32.5%) and 30.4% (95% UI 26.6% to 34.5%), respectively, from 1990 to 2019. The highest burden of metabolic-attributed total CVD and intracerebral haemorrhage was mainly in low SDI locations, while the highest burden of ischaemic heart disease and IS was mainly in high SDI locations. The burden of DALYs and deaths in CVD was higher in men than women. In addition, the number and ASR of DALYs and deaths were highest in those over 80 years old.
Metabolic-attributed CVD threatens public health, especially in low-SDI locations and among the elderly. Low SDI location should strengthen the control of metabolic factors such as high SBP, high BMI, and high LDL-c and increase the knowledge of metabolic risk factors for CVD. Countries and regions should enhance screening and prevention of metabolic risk factors of CVD in the elderly. Policy-makers should use 2019 GBD data to guide cost-effective interventions and resource allocation.
目前尚未有关于代谢相关性心血管疾病(CVD)负担的最新、详细的全球分析报告。因此,我们研究了过去 30 年中代谢相关性 CVD 的全球负担及其与社会经济发展状况的关系。
代谢相关性 CVD 负担数据来自 2019 年全球疾病负担(GBD)研究。CVD 的代谢危险因素包括空腹血糖升高、低密度脂蛋白胆固醇(LDL-c)升高、收缩压升高、体重指数升高和肾功能障碍。提取并按性别、年龄、社会人口指数(SDI)水平、国家和地区对残疾调整生命年(DALY)和死亡人数及年龄标准化率(ASR)进行分层。
1990 年至 2019 年,代谢相关性 CVD DALY 和死亡的 ASR 分别下降了 28.0%(95%置信区间 23.8%至 32.5%)和 30.4%(95%置信区间 26.6%至 34.5%)。代谢相关性总 CVD 和脑内出血的负担主要集中在 SDI 较低的地区,而缺血性心脏病和 IS 的负担主要集中在 SDI 较高的地区。CVD 的 DALY 和死亡负担男性高于女性。此外,DALY 和死亡人数及 ASR 在 80 岁以上人群中最高。
代谢相关性 CVD 对公众健康构成威胁,尤其是在 SDI 较低的地区和老年人中。低 SDI 地区应加强对高 SBP、高 BMI 和高 LDL-c 等代谢因素的控制,提高对 CVD 代谢危险因素的认识。各国和地区应加强对老年人 CVD 代谢危险因素的筛查和预防。决策者应利用 2019 年 GBD 数据来指导具有成本效益的干预措施和资源分配。